Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VeraCept Contraceptive Efficacy Study
NCT03633799Phase 3Active, not recruiting
- Sponsor
- Sebela Pharmaceuticals
- Start
- Aug 2018
- Primary completion
- Sep 2022
- Modality
- Device-based Delivery, DNA Intercalators/Alkylators, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of miudella in pregnancy, sponsored by Sebela Pharmaceuticals. Started Aug 2018; status: active, not recruiting.
02
Drugs
miudella
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT03633799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03633799.